Should I Buy ACU? ACU 2026 Analysis

Should You Buy Acme United Corp (ACU) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

41.150

1 Day change

-0.84%

52 Week Range

45.250

Analysis Updated At

2026/01/28

ACU is not a good buy right now for a beginner long-term investor who wants to act immediately. The stock is in a short-term bearish momentum phase (negative, expanding MACD) and the pattern-based outlook points to further downside over the next week/month, while recent fundamentals show profit/EPS deterioration. With no supportive trading signals today and no near-term news tailwinds, the risk/reward for buying immediately is unattractive; holding off is the better call.

Technical Analysis

Price/levels: Pre-market price is 41.5, which is below the pivot (42.659) and sitting just above first support S1 (40.979). A break below ~40.98 increases risk of a move toward S2 (~39.94). Upside resistance is around 42.66 (pivot) then 44.34 (R1). Trend/momentum: Moving averages are bullishly stacked (SMA_5 > SMA_20 > SMA_200), suggesting the longer-term trend has been up, but near-term momentum has turned down. MACD histogram is -0.233 and negatively expanding, which favors continued weakness until momentum stabilizes. RSI(6) at ~34.3 is near oversold but still not signaling a clear reversal. Quant-style short horizon read: Similar-pattern stats imply ~70% chance of small next-day drift (+0.31%) but meaningful expected weakness over the next week (-3.21%) and next month (-5.46%), aligning with the bearish MACD. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Positive Catalysts

Gross margin improved YoY (39.12%, +1.50% YoY), suggesting better pricing/mix or cost control.
Longer-term technical structure (bullish moving-average stack) indicates the broader trend hasn’t fully broken.
Upcoming earnings event: QDEC 2025 earnings scheduled for 2026-02-27 (pre-market) could re-rate the stock if profitability rebounds.

Neutral/Negative Catalysts

Short-term momentum is bearish: MACD histogram is negative and expanding, and price is below pivot with support nearby.
Pattern-based probabilities point to further downside over the next week and month.
No recent news catalysts to reverse sentiment.
Profitability weakened in the latest quarter (net income and EPS down ~15% YoY), which can cap upside until earnings improve.

Financial Performance

Latest quarter (2025/Q3): Revenue rose to $49.063M (+1.86% YoY), but net income fell to $1.903M (-14.51% YoY) and EPS fell to $0.46 (-14.81% YoY). Gross margin improved to 39.12% (+1.50% YoY). Overall: modest top-line growth, improving gross margin, but deteriorating bottom-line/EPS—suggesting higher operating costs/expenses or other below-the-line pressure.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a recent Wall Street upgrade/downgrade trend cannot be assessed. Pros typically would focus on margin improvement and longer-term uptrend structure; cons would focus on weakening net income/EPS and current bearish momentum. Politician/influential and congress activity: no recent congress trading data available, and no politician transaction data was provided.

Analyst Rating

Wall Street analysts forecast ACU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACU is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 41.500

Low

Averages

High